Browse study websites

Discover. Prevent. Cure.

Menu Fundraise Donate

    Recommended pages

      Do you mean

        311-320 of 617 results

        Refine search

        People

        Dr Janessa Pickering

        Janessa Pickering Dr BSc PhD Senior Research Fellow (currently HOT NORTH Early Career Fellow) 08 6319 1029 Janessa.pickering@telethonkids.org.au Dr ...

        08 6319 1029 Email me
        News & Events

        Nasal spray to prevent ear infections closer to fruition thanks to major grant

        A nasal spray that could potentially prevent childhood ear infections and reduce antibiotic use is a step closer to clinical trials thanks to a $500,000 CUREator grant. ...

        News & Events

        Trial tests which COVID-19 booster combos ‘boost’ immunity

        MEDIA ENQUIRIES Discover. Prevent. Cure. Mailing list Media contacts About Telethon Kids Institute Be Inspired Please direct general enquiries to our ...

        Research

        Statistical considerations for the platform trial in COVID-19 vaccine priming and boosting

        The Platform trial In COVID-19 priming and BOOsting (PICOBOO) is a multi-site, adaptive platform trial designed to generate evidence of the immunogenicity, reactogenicity, and cross-protection of different booster vaccination strategies against severe acute respiratory syndrome coronavirus 2 and its variants, specific for the Australian context. ...

        Research

        Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinics

        Children with chronic medical diseases are at an unacceptable risk of hospitalisation and death from influenza and SARS-CoV-2 infections. Over the past two decades, behavioural scientists have learnt how to design non-coercive 'nudge' interventions to encourage positive health behaviours. Our study aims to evaluate the impact of multicomponent nudge interventions on the uptake of COVID-19 and influenza vaccines in medically at-risk children. ...

        Research

        Characterization of invasive Group B Streptococcus isolates from Western Australian infants, 2004-2020

        Invasive Group B Streptococcus remains a leading cause of infant morbidity and mortality. Intrapartum antibiotic prophylaxis has been implemented in many countries with a reduction in early-onset disease, but an effective vaccine may further reduce the disease burden. Candidate vaccines targeting capsular polysaccharides and surface proteins are now in clinical trials.  ...

        News & Events

        WA Health funding supports development of rapid test for antibiotic-resistant skin infections in Aboriginal children

        A rapid test to detect antibiotic-resistant skin infections in Aboriginal children could be a step closer, thanks to support from the FHRIF. ...

        News & Events

        World-first trial to seek child-specific treatments for dangerous bloodstream infections

        Telethon Kids Institute, Perth Children’s Hospital (PCH) and the Peter Doherty Institute for Infection and Immunity (Doherty Institute) will spearhead the paediatric arm of a world-first global platform trial designed to uncover treatments for Staphylococcus aureus bloodstream infection. ...

        News & Events

        Telethon Kids Institute launches Covid-19 booster research to inform Australia’s vaccine policy

        Optimising our national Covid-19 vaccine program could be one step closer thanks to new research now underway at Telethon Kids Institute investigating the most effective, long-term strategies for booster vaccinations. ...

        News & Events

        Round one done, eight to go for the SToP Trial

        Six weeks, nine community visits and 380 kids – it’s a wrap for round one of the StoP Trial! ...

        Page 32 of 62